In particular, studies on animal models or in silico analyses of molecular pathways may be required before any advancements may be achieved in diagnosis, therapeutic and prognostic strategies of HNSCC based on circadian clock. The gene discussed is CLOCK; the disease is head and neck squamous cell carcinoma.